Physician profile
David B Keyes
NPI 1528039674
$600.04
in general payments reported to CMS, 2019-2025
9 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2022: $50.14 · 2023: $186 · 2024: $57.14 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $165.54 | 2024-2025 | |
| Depuy Synthes Sales INC. | $130.43 | 2022-2025 | Monovisc, Orthovisc |
| Medical Device Business Services, INC. | $112.12 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $99.57 | 2022-2023 | Seglentis |
| Kerecis Limited | $21.69 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ibsa Pharma INC. | $21.07 | 2023 | Tirosint, Licart |
| Electronic Waveform Lab, INC. | $18.56 | 2025 | |
| Henry Schein, INC. | $15.72 | 2025 | |
| Bioventus LLC | $15.34 | 2023 | Supartz Fx Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.